TOSITUMOMAB
UNII 0343IGH41U

Substance Identification & Data

This profile provides standardized clinical and technical data for Tositumomab, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 0343IGH41U.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 208921-02-2 and the RxNorm Concept ID (RxCUI) 263010. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
0343IGH41U
CAS Registry Number
208921-02-2
RxNorm Concept ID
263010

Detailed Substance Profile

Preferred Name
TOSITUMOMAB
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
C2543
National Cancer Institute reference terminology for clinical and research data.
INN ID
7827
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
protein
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Tositumomab. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

TOSITUMOMAB

Common Names & Synonyms

BEXXAR COMPONENT TOSITUMOMAB
TOSITUMOMAB [INN]
TOSITUMOMAB [MART.]
TOSITUMOMAB [MI]
TOSITUMOMAB [VANDF]
TOSITUMOMAB [WHO-DD]

Systematic Nomenclature

IMMUNOGLOBULIN G2A, ANTI-(HUMAN CD20 (ANTIGEN)) (MOUSE MONOCLONAL CLONE B1R1 .GAMMA.2A-CHAIN), DISULFIDE WITH MOUSE MONOCLONAL CLONE B1R1 .LAMBDA.X-CHAIN, DIMER

External Clinical & Regulatory Resources

CAS
Common Chemistry
NCATS
Inxight Drugs
NLM
DailyMed Products
NCATS
GSRS Full Record
NIH
NCI Thesaurus